Zevra Therapeutics (ZVRA) Amortizatization of Intangibles (2024 - 2026)

Zevra Therapeutics has reported Amortizatization of Intangibles for 3 years, with the latest figure at $118000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles changed N/A year-over-year to $118000.0; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (up 488.04% YoY), and the FY2025 full-year result was $3.1 million, up 466.67% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $118000.0, down from $857000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $1.2 million in Q3 2025, with the low at $118000.0 in Q1 2026.
• Historically, Amortizatization of Intangibles has averaged $759600.0 across 3 years, with a median of $857000.0 in 2025.
• The largest YoY upside for Amortizatization of Intangibles was 55.25% in 2025 against a maximum downside of 55.25% in 2025.
• Zevra Therapeutics' Amortizatization of Intangibles stood at $552000.0 in 2024, then jumped by 55.25% to $857000.0 in 2025, then sank by 86.23% to $118000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $118000.0 (Q1 2026), $857000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.